25.100
−6,34%
2026-10-13
Fundamental Analysis
78 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +112.4% | +94.4% | 3 / 3 | +3.2% | +6.74 pp | +9.09 pp | +3.0% | 0.00 | 16.96 | 204 | +3,2% | 2,0 | +112,4% | 16.96 | 28.48 | −40,4% |
| Pts | 12 | 12 | 12 | 0 | 12 | 12 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 25.100 (close price on 2026-10-13)EPS (TTM): 1.480
Financial charts
1.Revenue & growth
VND bn204Q2/26
1.Revenue & growth
VND bn204Q2/26
2.Profit & growth
VND bn-1,20Q2/26
3.Profit mix (Penman)
VND bn35,8Q2/26
4.Margins & cost structure
%28.4%Q2/26
5.Returns & cash cycle
% · days1.6%Q2/26
6.Earnings quality & cash
VND bn
7.Asset structure
VND bn1.622Q2/26
8.Funding & debt health
VND bn · times1.622Q2/26
9.Revenue backlog
VND bn260Q2/26
10.Valuation
times · %18,5×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-47Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
58.6%
averaged over 1 quarter(s)
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26